[Clinicopathologic study of splenic marginal zone B-cell lymphoma].

Yanning Zhang, Zheng Yuanyuan, Xiaoge Zhou, Shuhong Zhang, Yan Jin, Jianlan Xie, Shuyuan Chen, Yan Shi, Lihua WuPubMed 2009

Abstract

SMZL is an indolent B-cell non-Hodgkin lymphoma. The main clinical manifestations are splenomegaly and abnormalities in blood counts. The main modality of treatment is splenectomy. Adjuvant fludarabine-based chemotherapy helps to achieve complete remission. In general, the prognosis of this lymphoma type is good. The lymphoma cells predominantly grow in micronodular pattern, with atypical monocytoid B cells rimming around the small B cells, which aggregates in the center. The differential diagnosis includes other small B-cell lymphomas and lymphoid hyperplasia of spleen.
BibTeX
@inproceedings{zhang2009clinicopathologic,
  author = {Yanning Zhang and Zheng Yuanyuan and Xiaoge Zhou and Shuhong Zhang and Yan Jin and Jianlan Xie and Shuyuan Chen and Yan Shi and Lihua Wu},
  title = {{[Clinicopathologic study of splenic marginal zone B-cell lymphoma].}},
  booktitle = {PubMed},
  year = {2009},
}

Loading related content...

Figure